Facial Papules in Frontal Fibrosing Alopecia (FFA)
ConditionFrontal Fibrosing Alopecia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Miami
About this trial
The objective is to evaluate the safety and efficacy of the Cutera 1726 nm laser system (also referred to as AviClear) for the treatment of facial papules in frontal fibrosing alopecia (FFA).
Eligibility criteria
Qualifiers
Female or Male
Fitzpatrick Skin Types I-VI
At least 18 years of age
Has clinically diagnosed FFA with facial papules.
Disqualifiers
Prior treatment to the target area during participation in a clinical trial of another device or drug within 1 month (30 days) prior to study participation.
Prior treatment to the target area within 3 months of study participating including chemical peel, dermabrassion, microneedling, radiofrequency treatment, laser or light-based procedures, cryodestruction or chemodestruction, intralesional steroids, photodynamic therapy, or acne surgery.
Prior injection of botulinum toxin in the target area within 3 months of study participation and for the duration of the study.
Systemic use of retinoid, such as isotretinoin, within 3 months of study participation.
Trial design
Treatments tested in this trial
- Cutera® 1726 nm laser system
Treatment groups
10 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Miami
Lead sponsor
Cutera Inc.
Collaborator
Source ClinicalTrials.gov